Medical Care Technologies, Inc. (MDCE) Receives $10 Million Reserve Equity Financing From AGS Capital Group, LLC  
5/1/2012 7:17:21 AM

BEIJING, April 30, 2012 /PRNewswire/ -- Medical Care Technologies Inc. (OTCBB: MDCE), a growing children's healthcare service provider, is extremely pleased to announce that it has received a Reserve Equity Financing of US$10,000,000 over a term of 4 years.

The Reserve Equity Financing ("REF") with AGS Capital Group, LLC, is a comprehensive financing solution that will provide direct investment capital of up to $10 million without putting undue stress upon the Company's share capital structure. It is an inexpensive and flexible financing strategy in which the Company controls the amount of any advance and its timing the how and when, therefore, regulating and minimizing any potential impairment to its share structure.

"We believe this funding will provide us with the flexibility needed to expand our business," said Luis Kuo, Chief Operating Officer. "As the demand in China to implement our business model and to expand our children's health centers to other locations has been overwhelming, securing the right financing will give us the ability to manage both the long-term growth of the Company and shareholder value."

Ning Wu, Chief Executive Officer, stated, "We are excited to be entering into a relationship with a strong financial partner. It took research and many months to come to what we believe will turn the tides for Medical Care Technologies Inc. This type of financing will allow us to grow, concentrating our efforts on developing, building and staffing of children's health centers without the constant pressure of financing."

"We believe that there is a tremendous market in China for the services that Medical Care Technologies Inc. provides and see significant growth for the company during the next year," says Allen Silberstein, Chief Investment Officer of AGS Capital Group.

About Medical Care Technologies Inc.
Medical Care Technologies Inc. is traded under the symbol MDCE on the OTCBB and is headquartered in Beijing, China. MDCE, through joint ventures or Chinese subsidiaries, develops a network of children's health facilities in the larger urban areas throughout China. Services are geared towards the advancing economic middle-class and upper class Chinese families. Specializing in the care of children between the ages of 3 to 16, MDCE's role is to enhance the overall well-being of the family and community and to expand its pediatric services to include preventative health and wellness education. MDCE, through its children's health facilities, will also distribute a diverse range of industry-leading pharmaceutical and nutraceutical product lines. MDCE's main mission is simple to become a healthcare service provider leader in children's health. Information on the Company can be found at and the Company's website at

About AGS Capital Group, LLC
AGS Capital Group provides flexible equity financing solutions for growth-stage and mid cap public companies as well as private companies looking to go public. AGS Capital Group invests in public companies around the world listed on most exchanges. AGS Capital Group performs fundamental analysis including credit risk, technical analysis of market trends and industry, evaluation of management team experience and corporate structure evaluation. Additional information may be found at

Safe Harbor Statement
All statements contained in this press release, other than statements of historical fact, are forward-looking statements, including those regarding: MDCE's products, services, capabilities, performance, opportunities, development and business outlook, guidance on our future financial results and other projections or measures of our future performance; the amount and timing of the benefits expected from strategic initiatives and acquisitions or from deployment of new or updated technologies, products, services or applications; and other potential sources of additional revenue. These statements are based on our current plans and expectations and involve risks and uncertainties that could cause actual future events or results to be different than those described in or implied by such forward-looking statements. These risks and uncertainties include those relating to: lack of operating history, transitioning from a development company to an operating company, difficulties in distinguishing MDCE's products and services, ability to deploy MDCE's services and products, market acceptance of our products and services; operational difficulties relating to combining acquired companies and businesses; our ability to form and maintain mutually beneficial relationships with customers and strategic partners; changes in economic, political or regulatory conditions or other trends affecting the healthcare, Internet, information technology and healthcare and pharmaceutical industries, and our ability to attract and retain qualified personnel. Other risks and uncertainties may include, but are not limited to: lack of or delay in market acceptance and fluctuations in customer demand, dependence on a limited number of significant customers, reliance on third party vendors and strategic partners, ability to meet future capital requirements on acceptable terms, continuing uncertainty in the global economy, and compliance with federal and state regulatory requirement. Further information about these matters can be found in our Securities and Exchange Commission filings. We expressly disclaim any intent or obligation to update these forward-looking statements.

For Further Information:

Contact: Candy Wang

Tel: (852) 8122-9660

Contact: Yuen Chang

Tel: (852) 2893-5666



SOURCE Medical Care Technologies Inc.